Skip to main content

Table 2 Complete protection among enrolled patients (n = 329)

From: The effectiveness of NEPA in the prevention of chemotherapy-induced nausea vomiting among chemo naive patients in an Indian setting

Phases

Complete protection (%)

Enrolled patients (n = 329)

HEC (n = 260)

MEC (n = 69)

Acute phase

88.44

85.76

98.55

Delayed phase

81.76

81.15

84.05

Overall phase

80.54

79.61

84.05